304 related articles for article (PubMed ID: 25586691)
21. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
22. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
23. Precision therapy for lymphoma--current state and future directions.
Intlekofer AM; Younes A
Nat Rev Clin Oncol; 2014 Oct; 11(10):585-96. PubMed ID: 25135367
[TBL] [Abstract][Full Text] [Related]
24. [Personalized therapy of lung cancer - current standard and future challenges].
Riedel R; Wolf J
Dtsch Med Wochenschr; 2017 Nov; 142(22):1660-1668. PubMed ID: 29078211
[TBL] [Abstract][Full Text] [Related]
25. Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.
Zardavas D; Piccart-Gebhart M
Am Soc Clin Oncol Educ Book; 2015; ():e183-90. PubMed ID: 25993171
[TBL] [Abstract][Full Text] [Related]
26. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
27. "Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
Kurnit KC; Bailey AM; Zeng J; Johnson AM; Shufean MA; Brusco L; Litzenburger BC; Sánchez NS; Khotskaya YB; Holla V; Simpson A; Mills GB; Mendelsohn J; Bernstam E; Shaw K; Meric-Bernstam F
Cancer Res; 2017 Nov; 77(21):e123-e126. PubMed ID: 29092956
[TBL] [Abstract][Full Text] [Related]
28. Session 2: Mutational discordance: the big challenge in personalized treatments - any solutions?
Siddiqui M; Chand M; Eng C; Mehdizadeh A; Mirnezami A; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():49-51. PubMed ID: 29878676
[TBL] [Abstract][Full Text] [Related]
29. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
Yuen ST; Leung SY
Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
[TBL] [Abstract][Full Text] [Related]
30. [Personalized tumor therapy for gastrointestinal tumors].
Ettrich TJ; Perkhofer L; Seufferlein T
Internist (Berl); 2015 Sep; 56(9):1069-78. PubMed ID: 26148698
[TBL] [Abstract][Full Text] [Related]
31. Precision medicine for advanced prostate cancer.
Mullane SA; Van Allen EM
Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
[TBL] [Abstract][Full Text] [Related]
32. Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia.
Merajver S; Phadke S; Soellner M
Trans Am Clin Climatol Assoc; 2017; 128():169-179. PubMed ID: 28790501
[TBL] [Abstract][Full Text] [Related]
33. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
34. Clonotyping for precision oncology.
Dang HX; Maher CA
Drug Discov Today; 2015 Dec; 20(12):1464-9. PubMed ID: 26494143
[TBL] [Abstract][Full Text] [Related]
35. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
[TBL] [Abstract][Full Text] [Related]
36. Personalized therapy for lung cancer.
Moreira AL; Eng J
Chest; 2014 Dec; 146(6):1649-1657. PubMed ID: 25451351
[TBL] [Abstract][Full Text] [Related]
37. Toward precision medicine in glioblastoma: the promise and the challenges.
Prados MD; Byron SA; Tran NL; Phillips JJ; Molinaro AM; Ligon KL; Wen PY; Kuhn JG; Mellinghoff IK; de Groot JF; Colman H; Cloughesy TF; Chang SM; Ryken TC; Tembe WD; Kiefer JA; Berens ME; Craig DW; Carpten JD; Trent JM
Neuro Oncol; 2015 Aug; 17(8):1051-63. PubMed ID: 25934816
[TBL] [Abstract][Full Text] [Related]
38. The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis.
Kim ST; Lee J; Hong M; Park K; Park JO; Ahn T; Park SH; Park YS; Lim HY; Sun JM; Ahn JS; Ahn MJ; Kim HC; Sohn TS; Choi DI; Cho JH; Heo JS; Kwon W; Uhm SW; Lee H; Min BH; Hong SN; Kim DH; Jung SH; Park W; Kim KM; Kang WK; Park K
Oncotarget; 2015 Oct; 6(32):33358-68. PubMed ID: 26396172
[TBL] [Abstract][Full Text] [Related]
39. Genomic medicine: new frontiers and new challenges.
Pasic MD; Samaan S; Yousef GM
Clin Chem; 2013 Jan; 59(1):158-67. PubMed ID: 23284016
[TBL] [Abstract][Full Text] [Related]
40. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
